malaria

Beatriz Carreno, PhD, was featured Friday, April 3, on the syndicated radio show “Science Friday,” where she talked about School of Medicine research involving personalized melanoma vaccines. Carreno is the fourth faculty member in recent months to appear on the show.

Researchers led by Audrey Odom, MD, PhD, at Washington University School of Medicine in St. Louis have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery also is relevant for other infectious diseases including bacterial infections and tuberculosis.

Scientists may be able to entomb the malaria parasite in a prison of its own making, researchers at Washington University School of Medicine in St. Louis report July 16 in Nature.

A new study provides details that will help scientists design better vaccines and drug treatments for Plasmodium vivax (P. vivax) a dangerous form of malaria common in India, Southeast Asia and South America.

The April 12 conference at the School of Medicine is open to faculty, students and the public, but advance online registration by April 1 is encouraged. Shown is Joseph Gondovo, a patient in Nigeria who receives treatment for lymphatic filariasis, a neglected tropical disease that can cause grotesquely swollen limbs. ​

Researchers at Washington University School of Medicine in St. Louis have learned why changes in a single gene, ROP18, contribute substantially to dangerous forms of the parasite Toxoplasma gondii. The answer has likely moved science a step closer to new ways to beat Toxoplasma and many other parasites.

Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells. “Without this protein … the infectious process stops,” says Dan Goldberg, M.D.

Malaria, along with tuberculosis and HIV/AIDS, is one of the three largest global killers of the world’s poorest people.

Nobel Laureate Kenneth J. Arrow will discuss “The Economics of New Antimalarial Drugs” at 2:30 p.m. Oct. 21 in the Bryan Cave Courtroom, Anheuser-Busch Hall. Arrow, a longtime professor of economics at Stanford University, recently chaired a National Institute of Medicine committee that issued a report titled “Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance.” Malaria, along with tuberculosis and HIV/AIDS, is one of the big three global killers of the world’s poorest people.

Courtesy photoSculpture by Wesley Anderegg, Lompoc, CASo you think you know mosquitoes? Consider the venerable law that rainy weather is the cause of increased mosquito populations. An ecologist at Washington University in St. Louis says if you believe that, you’re all wet.